You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 07/28/2015

Company Name Symbol %Change
Potential Sanofi (SNY) Trade Targets 16.52% Return

Print Share

Dec 28, 2012 ( via COMTEX) -- Sanofi-Aventis (NYSE:SNY) closed Thursday's trading session at $47.51. In the past year, the stock has hit a 52-week low of $33.03 and 52-week high of $47.97. Sanofi (SNY) stock has been showing support around $46.72 and resistance in the $48.36 range. Technical indicators for the stock are Bullish and S&P gives Sanofi (SNY) a positive 4 STARS (out of 5) buy rating. For a hedged play on Sanofi (SNY), look at the Feb '13 $47.00 covered call for a net debit in the $45.96 area. That is also the break-even stock price for this trade. This covered call has a duration of 50 days, provides 3.26% downside protection and an assigned return rate of 2.26% for an annualized return rate of 16.52% (for comparison purposes only). Sanofi (SNY) has a current annual dividend yield of 3.03%.

(C) Copyright 2012, All rights reserved.


As of Monday, 12-24-2012 23:59, the latest Comtex SmarTrendA? Alert,
an automated pattern recognition system, indicated a DOWNTREND on
05-09-2012 for SNY @ $35.87.

For more information on SmarTrend, contact your market data
provider or go to

SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright A? 2004-2012 Comtex News Network, Inc. All rights reserved.

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.